Pharmaceutical
| Mon 18 May 2026
Beijing, May 18 -- Janssen Pharmaceutica and Protagonist Therapeutics have applied Chinese patent for Peptide Inhibitors of Interleukin-23 Receptor. Barrows Simon A, Neelamkavil Santhosh F, Sun Chengzao, Guo Boying, Hendrick Christopher, Marcus David, Somani Sanjay, Schau Thomas, Zhang Jing, Branca Danilo, Costant Romain, Bhanda..